The likelihood of elevated BP, stage 1 HTN, and stage 2 HTN based on metabolite-derived factors in crude model, model 1 (adjusting for age, sex, and BMI), and model 2 (adjusting for age, sex, BMI, total cholesterol, triglyceride, HDL cholesterol, FPG, oral glucose-lowering drugs use, statins use, and antihypertensive drugs use).